Biotech Showcase™ 2016: Interview: Garth Sutherland, CEO of Adherium Ltd

March 4, 2016
"Garth Sutherland, CEO of Adherium Ltd, tells Mike Ward, global director of content of Informa's pharma insights portfolio, about Adherium's endeavor in the digital health space. Sutherland outlines how the B2B digital health company, listed in Australia last year, is selling its Smartinhaler technology to big pharma, hospitals and disease management companies. The platform itself is made up of a cloud-based server that harbors data collected by Adherium's Smartinhaler, a medical device that records drug usage and can be clipped onto any prescribed inhaler used to treat asthma and COPD. Not only can the patient view the data collected on their smart phone or tablet, it can also be accessed by the patient's medical providers. Moreover, along with the data collection, the device provides patients with audio and visual reminders to take their medication.  Adherium recently signed a 10-year supply agreement with AstraZeneca and is attracting interest from health services like the UK’s NHS. Sutherland added that Adherium's platform, which is being used in over 30 countries, is being used in clinical trials, monitoring compliance in subjects, and has already generated and gathered a large amount of clinical data. With plans to grow the business further, the company is looking to expand internationally with hubs being set up in the US and Europe to provide market support. Sutherland is confident that this technology can be applied beyond respiratory conditions and help increase adherence in other chronic diseases.  Find more videos and articles at http://www.partnering360.com/insight For more information on Biotech Showcase™, visit our webpage: http://www.ebdgroup.com/bts/index.php
Previous Video
Biotech Showcase™ 2016: Interview: Probiodrug pursues modified abeta approach to tackle Alzheimer's
Biotech Showcase™ 2016: Interview: Probiodrug pursues modified abeta approach to tackle Alzheimer's

Probiodrug AG CEO Dr. Konrad Glund tells Mike Ward, global director of content for Informa's pharma insight...

Next Video
Biotech Showcase™ 2016: Interview: Prothena tackles diseases of protein accumulation
Biotech Showcase™ 2016: Interview: Prothena tackles diseases of protein accumulation

Prothena President and CEO Dr. Dale Schenk briefs Mike Ward, global director of content of Informa's pharma...